Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients.

ABSTRACT:

Background

Venous phlebotomy performed by trained personnel is critical for patient diagnosis and monitoring of chronic disease, but has limitations in resource-constrained settings, and represents an infection control challenge during outbreaks. Self-collection devices have the potential to shift phlebotomy closer to the point of care, supporting telemedicine strategies and virtual clinical trials. Here we assess a capillary blood micro-sampling device, the Tasso Serum Separator Tube (SST), for measuring blood protein levels in healthy subjects and non-hospitalized COVID-19 patients.

Methods

57 healthy controls and 56 participants with mild/moderate COVID-19 were recruited at two U.S. military healthcare facilities. Healthy controls donated Tasso SST capillary serum, venous

SUBMITTER: Brandsma J 

PROVIDER: S-EPMC9365123 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature